The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia (B-CLL) is decreased by thalidomide and fludarabine treatment

被引：0
|
作者：
Giannopoulos, K.
Schmitt, M.
Wlasiuk, P.
Chen, J.
Bojarska-Junak, A.
Kowal, M.
Rolinski, J.
Dmoszynska, A.
机构：
[1] Med Univ Lublin, Lublin, Poland
[2] Univ Ulm, Ulm, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0511
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [1] High frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia (B-CLL) is decreased by thalidomide and fludarabine treatment.
    Giannopoulos, Krzysztof
    Schmitt, Michael
    Wlasiuk, Paulina
    Kowal, Malgorzata
    Podhorecka, Monika
    Rolinski, Jacek
    Dmoszynska, Anna
    [J]. BLOOD, 2006, 108 (11) : 598A - 598A
  • [2] The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide
    K Giannopoulos
    M Schmitt
    P Własiuk
    J Chen
    A Bojarska-Junak
    M Kowal
    J Roliñski
    A Dmoszyñska
    [J]. Leukemia, 2008, 22 : 222 - 224
  • [3] The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide
    Giannopoulos, K.
    Schmitt, M.
    Wlasiuk, P.
    Chen, J.
    Bojarska-Junak, A.
    Kowal, M.
    Rolinski, J.
    Dmoszynska, A.
    [J]. LEUKEMIA, 2008, 22 (01) : 222 - 224
  • [4] T-cell function in patients with B-cell chronic lymphocytic leukemia (B-CLL) following alemtuzumab (Campath®) or fludarabine treatment.
    Kiaii, S
    Mozaffari, F
    Lundin, J
    Rezvany, R
    Chudhury, A
    Mellstedt, H
    Osterborg, A
    [J]. BLOOD, 2004, 104 (11) : 689A - 689A
  • [5] Allelotyping in B-cell chronic lymphocytic leukemia (B-CLL)
    Novak, U
    Tobler, A
    Fey, MF
    [J]. LEUKEMIA & LYMPHOMA, 2004, 45 (05) : 887 - 896
  • [6] In vitro and in vivo cytotoxicity of fludarabine in patients with advanced stage B-cell chronic lymphocytic leukemia (B-CLL)
    Hilgenfeld, E
    Knauf, WU
    Thiel, E
    [J]. DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 245 - 253
  • [7] Reconstitution of the T cell repertoire following treatment with alemtuzumab in patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Rezvany, MR
    Tehrani, MJ
    Karlsson, C
    Lundin, J
    Rabbani, H
    Mellstedt, K
    Österborg, A
    [J]. BLOOD, 2005, 106 (11) : 837A - 837A
  • [8] A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)
    Novak, U
    Leibundgut, EO
    Hager, J
    Mühlematter, D
    Jotterand, M
    Besse, C
    Leupin, N
    Ratschiller, D
    Papp, J
    Kearsey, G
    Aebi, S
    Graber, H
    Jaggi, R
    Lüthi, JM
    Meyer-Monard, S
    Lathrop, M
    Tobler, A
    Fey, MF
    [J]. BLOOD, 2002, 100 (05) : 1787 - 1794
  • [9] Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
    Montillo, Marco
    Ricci, Francesca
    Miqueleiz, Sara
    Tedeschi, Alessandra
    Morra, Enrica
    [J]. BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 41 - 52
  • [10] Quantitative and Qualitative Analysis of Regulatory T Cells (Tregs) in B Cell Chronic Lymphocytic Leukemia (B-CLL)
    Mpakou, Vassiliki
    Ioannidou, Dikea-Eleni
    Vikentiou, Myrofora
    Konsta, Eugenia
    Spathis, Aris
    Kontsioti, Frieda
    Kontos, Christos
    Vasilatou, Diamantina
    Bouchla, Anthi
    Gontopoulos, Kostas
    Roubakis, Christoforos
    Stavroulaki, Georgia
    Papanikolaou, Nikos
    Atta, Maria
    Papageorgiou, Sotiris
    Bazani, Efi
    Economopoulou, Christina
    Kokkori, Stela
    Kyriakou, Elias
    Dimitriadis, George
    Pappa, Vassiliki
    [J]. BLOOD, 2015, 126 (23)
12345